mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-06 |